The effects of lung afferents denervation on cardiovascular regulation can be assessed on bilateral lung transplantation patients. The high-frequency component of heart rate variability is known to be synchronous with breathing frequency. Then, if heart beat is neurally modulated by breathing frequency, we may expect disappearance of high frequency of heart rate variability in bilateral lung transplantation patients. On 11 patients and 11 matching healthy controls, we measured R-R interval (electrocardiography), blood pressure (Portapres â ) and breathing frequency (ultrasonic device) in supine rest, during 10-min free breathing, 10-min cadenced breathing (0Á25 Hz) and 5-min handgrip. We analysed heart rate variability and spontaneous variability of arterial blood pressure, by power spectral analysis, and baroreflex sensitivity, by the sequence method. Concerning heart rate variability, with respect to controls, transplant recipients had lower total power and lower low-and high-frequency power. The low-frequency/high-frequency ratio was higher. Concerning systolic, diastolic and mean arterial pressure variability, transplant recipients had lower total power (only for cadenced breathing), low frequency and low-frequency/high-frequency ratio during free and cadenced breathing. Baroreflex sensitivity was decreased. Denervated lungs induced strong heart rate variability reduction. The higher low-frequency/ high-frequency ratio suggested that the total power drop was mostly due to high frequency. These results support the hypothesis that neural modulation from lung afferents contributes to the high frequency of heart rate variability.
Introduction
Bilateral lung transplantation (BLT) carries along denervation of lung afferent cardiovascular sensitive nerves so that the graft is no longer connected to the autonomic nervous system (ANS) (Schaefers et al., 1990) . Thus, BLT is an excellent experimental model for the study of cardiovascular regulation without modulation of heart activity by parasympathetic and/ or sympathetic lung afferents. Breathing frequency (BF) is synchronous with and modulates the high-frequency peak (HF) of spontaneous heart rate variability (HRV) (Malliani et al., 1991; Taha et al., 1995; Perini & Veicsteinas, 2003) . If the ANS is the main modulator of HRV, then the HF of HRV would have to disappear after BLT.
The studies of autonomic modulation of HRV in BLT recipients (BLTR) are scanty (Schaefers et al., 1990; Iber et al., 1995) . Some were on children (Dalla Pozza et al., 2006; Pozza et al., 2006) and pointed to a demonstration of possible lung reinnervation after transplantation. Single lung transplant recipients were compared with either BLTR (Berakis et al., 2002) or lung and heart-lung transplant recipients (Seals et al., 1993) . No clear conclusion emerged on this subject from those works.
The aim of this study was to analyse the effects of lung denervation on HRV in BLTR as compared with healthy controls. The hypothesis was that the modulation of the HF component of HRV by the breathing frequency is mediated by the ANS. This hypothesis would be supported by the results if HF of HRV is suppressed in BLTR.
inflammatory disease, stable pulmonary function tests and without evidence of chronic or acute rejection or any other disease affecting the ANS. Patients with diabetes, either induced by pancreatic manifestations of cystic fibrosis or by immunosuppressant treatment, were excluded from the study. The patients' age ranged from 26 to 68 (mean value 49Á0 AE 14Á5 years). They were 168 AE 10 cm tall and weighed 62Á6 AE 12Á0 kg. Their transplant surgery took place between 6 months and 12 years (mean 3Á9 AE 3Á5 years) before their inclusion in the study. All their antirejection medications are reported in Table 1 .
Eleven healthy non-smoking subjects were recruited as controls so that each BLTR was coupled with a matching control for gender, age (AE2 years), height (AE5 cm) and weight (AE5 kg). Their age ranged from 25 to 69 (47Á8 AE 14Á1). They were 168 AE 10 cm tall and weighed 63Á6 AE 8Á9 kg. They had no history of cardiopulmonary disease and were not taking medications at the time of the experiments.
The subjects, all non-smokers since at least the surgery, abstained from coffee-containing products during the 12 h before the experiment. Experiments were carried out in the morning, between 9 and 11 a.m. On the day of testing, they had a light breakfast at 7 a.m. They were preliminarily informed of aims, design, protocol, procedures and risks associated with the experiments. Informed consent was obtained from each volunteer, who was aware of the right of withdrawing from the study at any time without jeopardy. The study was conducted in accordance with the Declaration of Helsinki. The protocol was approved by the institutional ethical committee.
Measurements
The R-R interval (RR) was continuously measured by electrocardiography (Elmed ETM 2 000, Heiligenhaus, Germany). Continuous recordings of arterial pulse pressure were obtained at the middle phalanx of the left hand's second finger, using a non-invasive cuff pressure recorder (Portapres, FMS, Amsterdam, The Netherlands). Systolic and diastolic blood pressure (SAP and DAP, respectively) were computed from each pulse pressure profile, using the Beatscope â software package (FMS, Amsterdam, The Netherlands). Beat-to-beat mean arterial pressure (MAP) was computed as the integral mean of each pressure profile, using the same software package. The BF was measured by an ultrasound device (Spiroson, Ecomedics, Suisse) plugged on a respiratory mask. All the signals were digitalized in parallel by a 16-channel A/D converter (MP150, Biopac Systems, Goleta CA, USA) and stored on a computer. The acquisition rate was 400 Hz.
Protocol
After instrumentation, the subject assumed the supine posture. After 5 min of quiet rest, the protocol started with 10 min of free breathing. It was followed by 10 min with cadenced breathing (0Á25 Hz). Eventually, the subjects underwent 5 min of handgrip contractions (30-50 contractions per minute without controlled BF), to induce an increase in sympathetic activity. All investigated variables were continuously recorded during the entire protocol.
Data treatment
The time series of RR, from the continuous recordings of ECG, and that of SAP and DAP, from pulse pressure profiles, were constructed. On these time series, power spectral analysis was performed to evaluate spontaneous variability of RR, SAP and DAP (Pagani et al., 1986) . The total power (P tot ) of RR, SAP and DAP variabilities, corresponding to the signal variance in the 0Á0-0Á5 Hz frequency range, was initially obtained. Subsequently, the powers and frequencies of the low (LF, 0Á04-0Á15 Hz)-and the high (HF, 0Á15-0Á4 Hz)-frequency spectral components were computed and expressed in absolute units. The LF/HF ratio was also calculated. The very low-frequency (VLF) component was neglected, because it can be measured only during very long recordings and it is a source of noise in the present experimental circumstances (Furlan et al., 1990) . Therefore, to infer on the relative weight of LF and HF in the spectra, they were normalized with respect to their sum made equal to 100% (LFnu et HFnu, respectively) after exclusion of the frequencies lower than 0Á03 Hz (Malliani et al., 1991; Pagani et al., 1986; Task force, 1996) . LFnu and HFnu were computed as:
and expressed in normalized units (nu) (Malliani et al., 1991) At rest and exercise steady states, we also computed baroreflex sensitivity (BRS, expressed in ms mmHg À1 ) by means of the sequence method (Bertinieri et al., 1988) . Briefly, sequences of three or more consecutive beats in which SAP and RR changed in the same direction, either increasing or , 1994, 1997) . For each subject, the mean slope of the RR versus SAP relationships was then computed and taken as a measure of individual BRS, at rest and at exercise, respectively. Spectral analysis and BRS were analysed by means of a purposely laboratory-made program written with MATLAB â software (Version 7Á9Á1 R2009b) (Costes et al., 2004; Assoumou et al., 2012; Dauphinot et al., 2013; Fontolliet et al., 2015) .
Statistics
Data are reported as mean AE standard deviation (SD) for each experimental session. The effects of transplantation on the investigated parameters were analysed by two-way ANOVA (McDonald, 2014) . When applicable, a Tukey post hoc test was used to locate significant differences. The Statistica 12© software package (StatSoft, Inc., Tulsa, OK, USA) was used. Differences were considered significant when P<0Á05.
Results

Mean measured data
The mean values of measured and calculated cardiovascular variables in all investigated conditions are shown in Fig. 1 . The heart rate was higher and thus RR lower, in BLTR than in controls, in all conditions. Cadenced breathing and handgrip did not affect RR. SAP, DAP and MAP were the same in patients and controls. With handgrip, SAP and DAP increased in control group and MAP increased in both groups. Baroreflex sensitivity was lower in BLTR than in controls, in every condition. Breathing frequency was higher in BLTR than in controls during free breathing (see Fig. 2 ).
Heart rate variability
The results of power spectral analysis for HRV are shown in Table 2 , top panel, for all subjects. P tot was lower in BLTR than in controls, because both the LF and the HF powers were lower. LFnu was higher and HFnu was lower in BLTR than in controls, in all investigated conditions. The LF/HF ratio was higher in BLTR than in controls in all conditions.
The absolute LF and HF powers of BLTR were characterized by large SD, because two patients were outliers: in fact, their LF and HF powers were so much higher than those of all other patients that they resulted more than two SDs above the mean group value (Fig. 3) . These patients were thus extracted from the group and analysed separately in comparison with their respective control counterparts.
The bottom panel of Table 2 reports the results of power spectral analysis for HRV, for the remaining patients group (n = 9). All differences with respect to the control group were significant, as they were for n = 11, except for the LF power during handgrip. For n = 9, in BLTR compared to controls, P tot was 93Á3 AE 7Á1% lower during free breathing, 89Á7 AE 13Á1% lower during cadenced breathing and 88Á3 AE 8Á9 lower during handgrip. The LF power was 82Á7 AE 24Á9% lower during free breathing and 94Á3 AE 7Á2% lower during cadenced breathing. The HF power was 95Á1 AE 5Á6% lower during free breathing, 97Á6 AE 4Á2% lower during cadenced breathing and 95Á3 AE 3Á2 lower during handgrip. Conversely, LFnu was higher and thus HFnu lower in BLTR than in controls, in all conditions. The LF/HF ratio was higher in the three investigated conditions.
Arterial pressure variability
The results of power spectral analysis for SAP, DAP and MAP are shown in Table 3 . Concerning SAP, P tot was lower in BLTR than in controls, in cadenced breathing (À51Á0 AE 36Á4%). The LF power was lower in BLTR than in controls, during free breathing (À41Á8 AE 42Á2%) and cadenced breathing (À72Á6 AE 21Á6%), but not during handgrip. HF power in patients was the same than in controls. The LF/HF ratio was lower in BLTR than in control, both in free breathing and in cadenced breathing.
Concerning DAP, P tot and LF power were lower in patients than in controls in cadenced breathing (respectively, À42Á2 AE 41Á9% and À22Á9 AE 84Á7%) and also in free breathing for LF power (À37Á2 AE 72Á6%). HF power was not different between BLTR and controls in any conditions. The LF/HF ratio was lower in BLTR than in controls in free breathing (À50Á2 AE 46Á2%) and cadenced breathing (À9Á6 AE 3Á3%). Concerning MAP, P tot and LF power were lower in patients than in controls in cadenced breathing (respectively, À23Á2 AE 49Á8% and À11Á3 AE 114Á4%) and also in free breathing for LF power (À20Á1 AE 85Á2%). The LF/HF ratio was lower in BLTR than in controls (À76Á2 AE 77Á2% in free breathing, À76Á9 AE 66Á4% in cadenced breathing and À50Á7 AE 62Á0% in handgrip).
The results of power spectral analysis for HRV of the two outliers and their respective control counterparts are shown in Table 4 . All data were closer to controls' results than for the rest of the patients. Results were still lower for the two outliers than for their respective control counterparts.
Discussion
In this study, we tested the hypothesis that the modulation of the HF component of HRV by BF is mediated by afferent fibres from the lungs that are interrupted after BLT. To this aim, we investigated the effects of BLT on HRV. The tested hypothesis would be fully supported by the results if the HF component of HRV was suppressed after BLT. The data show that P tot and the LF and HF powers were strongly reduced in BLTR, a finding in substantial agreement with the tested hypothesis. We can, therefore, state that most of the spontaneous HR oscillations at rest are affected by neural afferents coming from the lungs. Nevertheless, some degree of spontaneous HRV remained in BLTR, suggesting that some of the overall HRV is related to other mechanisms than a modulation of cardiovascular centres by lung afferents. Moreover, if we look at normalized data, LFnu resulted higher and HFnu lower in BLTR than in controls, suggesting that the remaining variability in BLTR might have been under predominant sympathetic modulation.
We note, however, that in two BLTR spontaneous HRV was only partially reduced. Their LF and HF powers were more than two standard deviations above the mean group value. If the tested hypothesis was correct, this would mean that the neural efflux through lung afferents was present in these patients, implying the possibility of at least partial Figure 1 The mean cardiac values and standard deviations measured and calculated at steady state in supine position in all investigated conditions (n = 11). HR, heart rate; RR, R-R interval; SAP, systolic arterial pressure; DAP, diastolic arterial pressure; MAP, mean arterial pressure; BRS, baroreflex sensitivity; FB, free breathing; CB, cadenced breathing; HG, handgrip; *, significantly different from controls; #, significantly different from FB for the same group. reinnervation after complete lung denervation. This was not a direct effect of time after intervention, as the two patients who had, by far, the oldest surgery had very low HRV values, compared to other patients with more recent intervention. Antirejection medication cannot explain the different behaviour of the two outliers, as they had the same treatment as the other patients. In particular, they were both under tacrolimus, which if any would have prevented the resurgence of HRV due to its neurotoxic effects. In fact, the outliers were the two youngest patients, who were operated when they were 22 and 28 years old, respectively, 3Á5 and 2Á7 years before our study. As nerve plasticity is more efficient in younger than in later life (Burke & Barnes, 2006; Kumar et al., 2012; Kempsell & Fieber, 2015) , we speculate that three years may have been enough, in these two patients, to recover afferent neural fibres between lungs and cardiorespiratory centres. It would be interesting to repeat the experiments on these patients in 2-4 years: if the hypothesis of a gradual reinnervation of transplanted lungs holds, we would expect a progressive increase in the power of the HF peak.
The HF peak of HRV was centred around a 0Á30-Hz frequency in BLTR, while it was located around 0Á20 Hz in controls, coherently with the finding that spontaneous BF was higher in BLTR than in controls. During cadenced breathing, the HF peak of HRV in controls was higher than during free breathing. These observations confirm that the HF peak is modulated by the breathing cycle mechanism, as pointed out by several authors (Malliani et al., 1991; Taha et al., 1995; Perini & Veicsteinas, 2003) . By contrast, in BLTR, the power of the HF peak was extremely low, whether during free Figure 2 The mean breathing values and standard deviations measured at steady state in supine position in supine position in all investigated conditions (n = 11). FB, free breathing; CB, cadenced breathing; HG, handgrip; *, significantly different from controls; #, significantly different from FB for the same group. Top panel, eleven patients and controls; Bottom panel, nine patients and controls; HRV, heart rate variability; P tot , total power; LF, low-frequency power; HF, high-frequency power; LF/HF, low-frequency to high-frequency ratio; LFnu, normalized LF power; HFnu, normalized HF power; P, patients; C, controls; FB, free breathing; CB, cadenced breathing; HG, handgrip. a significantly different from controls.
breathing or during cadenced breathing, more than 100 times lower than in controls. This is compatible with the notion that lung denervation suppressed most of the HF peak.
Also, the LF power was smaller in BLTR than in controls, but not as much as the HF power. During handgrip, no difference between BLTR and controls was found, whereas in free and cadenced breathing, the LF power was some 10 times smaller in BLTR than in controls. This suggests that the LF peak was less affected than the HF peak by the breathing patterns.
Although the hypothesis that a neural modulation from lung afferents determines most of the HF component of HRV is essentially supported by the present results, there remains a component of spontaneous HRV that must be related to different mechanisms. We speculate that oscillations in heart filling, Table 3 Mean and standard deviations of all parameters calculated by mean of systolic arterial pressure, diastolic arterial pressure, mean arterial pressure at steady state, in supine position in the three investigated conditions.
Free breathing
Cadenced breathing
Handgrip
SAP, systolic arterial pressure; DAP, diastolic arterial pressure; MAP, mean arterial pressure; P tot , total power; LF, low-frequency power; HF, high-frequency power; LF/HF, low-frequency to high-frequency ratio; LFnu, normalized LF power; HFnum, normalized HF power; P, patients; C, controls. a significantly different from controls. Table 4 Parameters calculated by means of heart rate variability, in supine position in the three investigated conditions, for the two outliers and respective control counterparts.
HRV Patient 6
Control 6
Patient 10 Control 10
HRV, heart rate variability; P tot , total power; LF, low-frequency power; HF, high-frequency power; LF/HF, low-frequency to high-frequency ratio; LFnu, normalized LF power; HFnu, normalized HF power; FB, free breathing; CB, cadenced breathing; HG, handgrip. and thus in central venous pressure, following changes in lung volumes may stimulate atrial low-pressure cardiac baroreceptor. This might correct the oscillations in central venous pressure synchronous with changes in lung volume by means of compensatory heart rate oscillations, whence a surviving LF and HF component in BLTR.
Concerning spontaneous variability of SAP and DAP, differences between BLTR and controls were smaller than for HRV. The HF power did not differ between BLTR and controls in any condition. No differences between patients and controls were observed during handgrip for any of the investigated parameters. This means that blood pressure variability was poorly affected, much less than HRV, by lung denervation. The LF power of SAP is linked to peripheral sympathetic modulation (Pagani et al., 1997) . Notwithstanding, the LF/HF ratio was higher, and consistently, LFnu was higher and HFnu lower in BLTR than in controls, suggesting predominant sympathetic modulation of HR in patients. Thus, the lower LF power of SAP in BLTR would confirm the dissociation between modulation mechanisms involved in arterial pressure variability, representing the peripheral oscillatory component, and HRV, representing the cardiac oscillatory component. We speculate that the lung afferents to the cardiovascular centres affect specifically the central (heart) component of cardiovascular modulation by the ANS. Yet we acknowledge that meaning and links between LF and fluctuation in the modulation of the ANS are highly disputed in literature (Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, 1996; Eckberg, 1997; Malliani et al., 1998; Notarius et al., 2001; Billman, 2011 Billman, , 2013 , so that some authors (Eckberg, 1997; Goldstein et al., 2011; Billman, 2013; Heathers, 2014) proposed that the LF power is a poor indicator of sympathetic heart modulation.
The analysis of HRV is a potentially useful tool in different clinical settings (La Rovere et al., 2003) . Cardiac autonomic dysfunction changes HRV and is a risk factor of cardiovascular diseases (Pipilis et al., 1991 ; Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, 1996) . An evaluation of cardiac autonomic dysfunction by HRV helps predicting cardiac issues. Low HRV is, for example, associated with higher risk of heart failure (Tuininga et al., 1994; Sandercock & Brodie, 2006) , sudden cardiac death (Kudaiberdieva et al., 2007) and mortality after myocardial infarction (Wolf et al., 1978; Kleiger et al., 1987; Dougherty & Burr, 1992) . In the case of BLTR, atherosclerotic diseases are potentially accelerated by immunosuppressive therapy (Kasiske, 1988; Hruban et al., 1990) . Then, coronary artery diseases are not uncommon in BLTR (Reed et al., 2012; Castleberry et al., 2013) .
The remarkable differences between BLTR and controls imply that HRV analysis may represent a sensitive tool for assessing autonomic improvements in BLTR follow-up. For example, exercise training, improving exercise capacity also in BLTR (Wickerson et al., 2010) , carries along an increased vagal modulation of the heart (Levy et al., 1998) , which may be reflected by a decrease in the LF/HF ratio. Moreover, progressive heart reinnervation after surgery may translate into an increased P tot , LF and HF of HRV, making the BLTR spectra closer to those of healthy subjects. Under this respect, a stimulating perspective is opened by the two young patients who showed P tot values more than two standard deviations higher than the group mean. These patients were the two youngest investigated BLTR and also the youngest at the time of surgery. A follow-up study on young BLTR from operation would inform on whether indexes of HRV progress towards normalization as time after operation goes on.
Concerning BRS, we observed a drastic reduction in BLTR with respect to controls in every condition. Autonomic alterations with reduced vagal or increased sympathetic nerve activity are always accompanied by decreased BRS (Billman et al., 1982; Schwartz et al., 1988; La Rovere et al., 2001) . This is especially true during exercise (Perini & Veicsteinas, 2003) . The reduced BRS is therefore consistent with the observed increase in LFnu in BLTR. As physical training increases BRS (La Rovere et al., 2002) , it would be relevant for BLTR to systematically enter a training programme and useful for clinical teams to exactly know how they respond to it.
A limitation of this study concerns the fact that this is a transversal study, wherein we compared BLTR to healthy subjects, instead of a longitudinal study, with the same patients being studied before and after BLT. Thus, we acknowledge that the attribution to lung denervation of the observed effects of HRV and BRS was indirect, not direct: performance of a longitudinal study would be needed to further reinforce the present interpretation. Another point is the transplant medication that can cause side effects on both the central and peripheral nervous system. For example, tacrolimus, used on nine of our eleven patients, is well known to have neuropathies associated with it. Thus, we cannot totally exclude that the lack of HRV may be due to a neurotoxic effect of tacrolimus. Nevertheless, the fact that the two outliers were also under tacrolimus speaks against this second hypothesis.
Conclusion
From a physiological viewpoint, lung denervation carried along an important reduction in HRV, indicating that neural modulation from lung afferents contributes largely to HRV. The higher LF/HF ratio implies that the P tot drop was mostly due to the HF component. In contrast, the effects of lung denervation on blood pressure variability were much smaller than on HRV. This suggests that the effects of lung denervation were specific to HRV modulation and confirms that blood pressure variability and HRV are under different control mechanisms.
Clinically speaking, it is very important for physicians to be aware that BLTR have a decreased cardiac autonomic regulation with a global and remarkable reduction in all parameters related to HRV spectral analysis. Those patients need an appropriate training programme to be strengthened, and it would be very useful to quantify exactly how they respond to it. Further research could evaluate HRV indices as sensitive tool for assessing autonomic improvements in BLTR follow-up.
